Prolonged use of bedaquiline in the treatment for MDR-TB in a child

Bedaquiline (Bdq), a novel TB drug, is referred to the most effective drugs and used for the management of multidrug-resistant tuberculosis (MDR-TB). The drug produces a cardiotoxic effect, and its use is limited to six months. We describe a clinical observation of prolonged bedaquiline use in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gubkina, Marina F., Khokhlova, Julia Yu., Yukhimenko, Natalia V., Petrakova, Irina Yu.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551576/
https://www.ncbi.nlm.nih.gov/pubmed/34745886
http://dx.doi.org/10.1016/j.idcr.2021.e01311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551576/
https://www.ncbi.nlm.nih.gov/pubmed/34745886
http://dx.doi.org/10.1016/j.idcr.2021.e01311

Ejemplares similares